Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

1.

Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results.

Vizio B, Novarino A, Giacobino A, Cristiano C, Prati A, Brondino G, Ciuffreda L, Bellone G.

Cancer Sci. 2010 Nov;101(11):2448-54. doi: 10.1111/j.1349-7006.2010.01692.x.

PMID:
20950371
[PubMed - indexed for MEDLINE]
2.

Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy.

Bellone G, Novarino A, Chiappino I, Gramigni C, Carbone A, Addeo A, Tonel E, Bertetto O, Emanuelli G.

Anticancer Res. 2005 Sep-Oct;25(5):3287-91.

PMID:
16101140
[PubMed - indexed for MEDLINE]
Free Article
3.

Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.

Twardowski PW, Smith-Powell L, Carroll M, VanBalgooy J, Ruel C, Frankel P, Synold TW.

Cancer Invest. 2008 Feb;26(1):53-9. doi: 10.1080/07357900701681541.

PMID:
18181046
[PubMed - indexed for MEDLINE]
4.

Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.

Robak E, Kierstan M, Cebula B, Krawczynska A, Sysa-Jedrzejowska A, Wierzbowska A, Smolewski P, Robak T.

Lupus. 2009 Apr;18(4):332-41. doi: 10.1177/0961203308097572.

PMID:
19276301
[PubMed - indexed for MEDLINE]
5.

High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.

Taylor M, Rössler J, Geoerger B, Laplanche A, Hartmann O, Vassal G, Farace F.

Clin Cancer Res. 2009 Jul 15;15(14):4561-71. doi: 10.1158/1078-0432.CCR-08-2363.

PMID:
19605404
[PubMed - indexed for MEDLINE]
Free Article
6.

[Circulating endothelial cells, endothelial precursors, VEGF and bFGF concentrations in patients with acute leukemias, lymphomas and myelomas].

Poreba M, Jaźwiec B, Kuliczkowski K, Poreba R.

Pol Arch Med Wewn. 2005 Jan;113(1):27-34. Polish.

PMID:
16130598
[PubMed - indexed for MEDLINE]
7.

Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.

Pohl M, Werner N, Munding J, Tannapfel A, Graeven U, Nickenig G, Schmiegel W, Reinacher-Schick A.

Z Gastroenterol. 2011 Oct;49(10):1398-406. doi: 10.1055/s-0031-1281752. Epub 2011 Sep 30. Review.

PMID:
21964893
[PubMed - indexed for MEDLINE]
8.

Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.

Di Raimondo F, Azzaro MP, Palumbo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R.

Haematologica. 2000 Aug;85(8):800-5.

PMID:
10942925
[PubMed - indexed for MEDLINE]
Free Article
9.

Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment.

Starlinger P, Brugger P, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C.

Neoplasia. 2011 May;13(5):419-27.

PMID:
21532882
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide.

Young RJ, Tin AW, Brown NJ, Jitlal M, Lee SM, Woll PJ.

Br J Cancer. 2012 Mar 13;106(6):1153-9. doi: 10.1038/bjc.2012.50. Epub 2012 Feb 21.

PMID:
22353811
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme.

Greenfield JP, Jin DK, Young LM, Christos PJ, Abrey L, Rafii S, Gutin PH.

Neurosurgery. 2009 May;64(5):819-26; discussion 826-7. doi: 10.1227/01.NEU.0000343742.06625.DB.

PMID:
19404145
[PubMed - indexed for MEDLINE]
12.

Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients.

Igreja C, Courinha M, Cachaço AS, Pereira T, Cabeçadas J, da Silva MG, Dias S.

Haematologica. 2007 Apr;92(4):469-77.

PMID:
17488657
[PubMed - indexed for MEDLINE]
Free Article
13.

Serum vascular endothelial growth factors a, C and d in human breast tumors.

Gisterek I, Matkowski R, Lacko A, Sedlaczek P, Szewczyk K, Biecek P, Halon A, Staszek U, Szelachowska J, Pudelko M, Bebenek M, Harlozinska-Szmyrka A, Kornafel J.

Pathol Oncol Res. 2010 Sep;16(3):337-44. doi: 10.1007/s12253-009-9211-8. Epub 2009 Oct 11.

PMID:
19821158
[PubMed - indexed for MEDLINE]
14.

Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.

Zhu Y, Tibensky I, Schmidt J, Hackert T, Ryschich E, Jäger D, Büchler MW, Märten A.

J Immunother. 2008 Jan;31(1):28-33.

PMID:
18157009
[PubMed - indexed for MEDLINE]
15.

Circulating endothelial cells as a novel marker of angiogenesis.

Mancuso P, Calleri A, Cassi C, Gobbi A, Capillo M, Pruneri G, Martinelli G, Bertolini F.

Adv Exp Med Biol. 2003;522:83-97.

PMID:
12674213
[PubMed - indexed for MEDLINE]
16.

Circulating endothelial cells in patients with acute myeloid leukemia.

Wierzbowska A, Robak T, Krawczyńska A, Wrzesień-Kuś A, Pluta A, Cebula B, Smolewski P.

Eur J Haematol. 2005 Dec;75(6):492-7.

PMID:
16313261
[PubMed - indexed for MEDLINE]
17.

Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.

Gritti G, Cortelezzi A, Bucciarelli P, Rezzonico F, Lonati S, La Marca S, Silvestris I, Federici AB.

Am J Hematol. 2011 Aug;86(8):650-6. doi: 10.1002/ajh.22070. Epub 2011 May 31.

PMID:
21630316
[PubMed - indexed for MEDLINE]
18.

[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].

Gong JF, Zhang XD, Li J, Di LJ, Jin ML, Shen L.

Ai Zheng. 2007 Aug;26(8):890-4. Chinese.

PMID:
17697554
[PubMed - indexed for MEDLINE]
19.

Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis.

Tawada K, Ishihara T, Kobayashi A, Yamaguchi T, Tsuyuguchi T, Matsuyama M, Yokosuka O.

Clin Cancer Res. 2008 Nov 15;14(22):7438-43. doi: 10.1158/1078-0432.CCR-07-4980. Epub 2008 Oct 30.

PMID:
18974391
[PubMed - indexed for MEDLINE]
Free Article
20.

High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.

Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B.

Clin Cancer Res. 2009 Mar 1;15(5):1741-6. doi: 10.1158/1078-0432.CCR-08-1372. Epub 2009 Feb 24.

PMID:
19240177
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk